Stephen Liu: Dr. Solange Peters at Rome Lung 24 with a dynamic discussion of next-generation ICIS

Stephen Liu shared on X:

“Dr. Solange Peters at Rome Lung 24 with a dynamic discussion of next-generation checkpoint inhibitors. Beyond PDL1, many disappointments but the future is bright with novel targets and elegant bispecific antibodies.”

Source: Stephen Liu/X

Stephen Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center. As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies.

His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer. Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.

Solange Peters is the past president of the European Society of Medical Oncology (ESMO). She is a professor and chair of medical oncology and the thoracic malignancies program in the Department of Oncology at the University Hospital of Lausanne in Lausanne, Switzerland.

Additionally, she acts as the scientific committee chair and Foundation Council member of the European Thoracic Oncology Platform, and Member of the Board of Directors of the International Association for the Study of Lung Cancer (IASLC).

She was recently nominated as the Strategic Advisory Board President of the Paris Saclay Cancer Cluster and is part of the Board of Directors of the Swiss National Cancer League. Prof. Peters created the ESMO Women for Oncology Committee.